Tom J. Harryvan

885 total citations
15 papers, 642 citations indexed

About

Tom J. Harryvan is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Tom J. Harryvan has authored 15 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Tom J. Harryvan's work include Cancer Cells and Metastasis (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Tom J. Harryvan is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Tom J. Harryvan collaborates with scholars based in Netherlands, Sweden and Denmark. Tom J. Harryvan's co-authors include Els M.E. Verdegaal, Sjoerd H. van der Burg, Lukas J.A.C. Hawinkels, Noel F.C.C. de Miranda, Ton N. Schumacher, Rikke Andersen, Marit M. van Buuren, Hergen Spits, Remko Schotte and John B.A.G. Haanen and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Tom J. Harryvan

13 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom J. Harryvan Netherlands	10	449	340	242	101	62	15	642
Leah Schmidt United States	4	409 0.9×	336 1.0×	268 1.1×	131 1.3×	78 1.3×	5	706
Bradley N. Bidwell Australia	5	429 1.0×	279 0.8×	290 1.2×	179 1.8×	69 1.1×	8	751
Jonathan Chabon United States	5	505 1.1×	466 1.4×	259 1.1×	72 0.7×	74 1.2×	7	819
Manami Shimomura Japan	15	360 0.8×	345 1.0×	328 1.4×	76 0.8×	52 0.8×	35	763
Akira Yuno United States	16	411 0.9×	383 1.1×	459 1.9×	66 0.7×	71 1.1×	29	844
Marit M. Melssen United States	13	391 0.9×	484 1.4×	205 0.8×	69 0.7×	63 1.0×	20	695
Karthik Dhatchinamoorthy United States	6	338 0.8×	345 1.0×	274 1.1×	74 0.7×	65 1.0×	7	655
Maria M. Martins Brazil	4	492 1.1×	443 1.3×	164 0.7×	65 0.6×	67 1.1×	11	738
Anthony Miliotto United States	13	559 1.2×	570 1.7×	255 1.1×	65 0.6×	63 1.0×	23	866
Hannah Dada United States	2	666 1.5×	588 1.7×	206 0.9×	89 0.9×	112 1.8×	2	892

Countries citing papers authored by Tom J. Harryvan

Since Specialization

Citations

This map shows the geographic impact of Tom J. Harryvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom J. Harryvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom J. Harryvan more than expected).

Fields of papers citing papers by Tom J. Harryvan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom J. Harryvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom J. Harryvan. The network helps show where Tom J. Harryvan may publish in the future.

Co-authorship network of co-authors of Tom J. Harryvan

This figure shows the co-authorship network connecting the top 25 collaborators of Tom J. Harryvan. A scholar is included among the top collaborators of Tom J. Harryvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom J. Harryvan. Tom J. Harryvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Harryvan, Tom J., Kristiaan Lenos, Tamsin R.M. Lannagan, et al.. (2025). TGFβ signaling in cancer-associated fibroblasts drives a hepatic gp130-dependent pro-metastatic inflammatory program in colorectal cancer. iScience. 28(11). 113696–113696.

Harryvan, Tom J., et al.. (2023). Endoglin and squamous cell carcinomas. Frontiers in Medicine. 10. 1112573–1112573. 3 indexed citations

Harryvan, Tom J., et al.. (2023). Preclinical evaluation of the gorilla‐derived HAdV‐B AdV‐lumc007 oncolytic adenovirus ‘GoraVir’ for the treatment of pancreatic ductal adenocarcinoma. Molecular Oncology. 18(5). 1245–1258. 4 indexed citations

Dang, Hao, Tom J. Harryvan, Erik H.J. Danen, et al.. (2023). Cancer-Associated Fibroblasts Are Key Determinants of Cancer Cell Invasion in the Earliest Stage of Colorectal Cancer. Cellular and Molecular Gastroenterology and Hepatology. 16(1). 107–131. 13 indexed citations

Harryvan, Tom J., Lukas J.A.C. Hawinkels, Akin Inderson, et al.. (2022). A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation. SHILAP Revista de lepidopterología. 1(4). 678–681. 13 indexed citations

Harryvan, Tom J., Arend Mulder, Peter A. van Veelen, et al.. (2022). Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. Journal for ImmunoTherapy of Cancer. 10(3). e003591–e003591. 28 indexed citations

Harryvan, Tom J., Nicole M. van Dam, Mark J.A. Schoonderwoerd, et al.. (2022). Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirus. Cancer Gene Therapy. 29(12). 1918–1929. 9 indexed citations

Dang, Hao, Tom J. Harryvan, & Lukas J.A.C. Hawinkels. (2021). Fibroblast Subsets in Intestinal Homeostasis, Carcinogenesis, Tumor Progression, and Metastasis. Cancers. 13(2). 183–183. 14 indexed citations

Harryvan, Tom J., et al.. (2021). The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells. International Journal of Molecular Sciences. 23(1). 137–137. 16 indexed citations

10.

Harryvan, Tom J., Els M.E. Verdegaal, James C.H. Hardwick, Lukas J.A.C. Hawinkels, & Sjoerd H. van der Burg. (2019). Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies. Journal of Clinical Medicine. 8(11). 1989–1989. 46 indexed citations

11.

Paauwe, Madelon, Mark J.A. Schoonderwoerd, Roxan F.C.P. Helderman, et al.. (2018). Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis. Clinical Cancer Research. 24(24). 6331–6344. 132 indexed citations

12.

Harryvan, Tom J., Linde M. Morsink, & Maarten E. Tushuizen. (2018). A Middle-Aged Man With Jaundice and a Gastric Tumor. Gastroenterology. 155(6). 1699–1700.

13.

Harryvan, Tom J. & Maarten E. Tushuizen. (2018). A Young Patient With Diabetes and Liver Tumors. Gastroenterology. 155(1). 25–26. 4 indexed citations

14.

Verdegaal, Els M.E., Noel F.C.C. de Miranda, Marten Visser, et al.. (2016). Neoantigen landscape dynamics during human melanoma–T cell interactions. Nature. 536(7614). 91–95. 339 indexed citations

15.

Vicente‐Steijn, Rebecca, Tom J. Harryvan, Georgios Kosmidis, et al.. (2015). The sinus venosus myocardium contributes to the atrioventricular canal: potential role during atrioventricular node development?. Journal of Cellular and Molecular Medicine. 19(6). 1375–1389. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact